title: [Correction of erectile dysfunction in patients undergoing radical prostatectomy].
abstract: Radical prostatectomy (RPE) is a widespread surgery in the world performed in patients with localized prostate cancer. Despite the widespread introduction of nerve-sparing radical prostatectomy techniques, erectile dysfunction after radical prostatectomy occurs very frequently, which seriously affect the quality of life of patients. At the present stage of development of medicine, differentiated approach to each patient is required. "Patient's expectation management" is an important prerequisite for successful sexual rehabilitation. The use of conventional methods for correction of erectile dysfunction after radical prostatectomy has its own characteristics. Currently, phosphodiesterase type 5 inhibitors, however, are still first-line agents for the recovery of erectile function. Their combined use with other methods has encouraging results.
authors: S O
authors: SO
authors: Iudovskiĭ
authors: D Iu
authors: DIu
authors: Pushkar'
mesh_terms: D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D011468:Prostatectomy / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000503:physiopathology / Q000601:surgery*
chemical_list: D058986:Phosphodiesterase 5 Inhibitors